Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP247226.RAI9cciKArP5LPh39c3QKXzcubZS9cWw01X0ICLcJ5l7A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP247226.RAI9cciKArP5LPh39c3QKXzcubZS9cWw01X0ICLcJ5l7A130_assertion type Assertion NP247226.RAI9cciKArP5LPh39c3QKXzcubZS9cWw01X0ICLcJ5l7A130_head.
- NP247226.RAI9cciKArP5LPh39c3QKXzcubZS9cWw01X0ICLcJ5l7A130_assertion description "[In conclusion, the lack of association between AR and most clinicopathological features and survival, together with the absence of prognostic value for ER/PGR status, suggest that MBCs are biologically different from female breast carcinomas and make it questionable to use antihormonal therapy for patients with MBC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247226.RAI9cciKArP5LPh39c3QKXzcubZS9cWw01X0ICLcJ5l7A130_provenance.
- NP247226.RAI9cciKArP5LPh39c3QKXzcubZS9cWw01X0ICLcJ5l7A130_assertion evidence source_evidence_literature NP247226.RAI9cciKArP5LPh39c3QKXzcubZS9cWw01X0ICLcJ5l7A130_provenance.
- NP247226.RAI9cciKArP5LPh39c3QKXzcubZS9cWw01X0ICLcJ5l7A130_assertion SIO_000772 10070897 NP247226.RAI9cciKArP5LPh39c3QKXzcubZS9cWw01X0ICLcJ5l7A130_provenance.
- NP247226.RAI9cciKArP5LPh39c3QKXzcubZS9cWw01X0ICLcJ5l7A130_assertion wasDerivedFrom befree-2016 NP247226.RAI9cciKArP5LPh39c3QKXzcubZS9cWw01X0ICLcJ5l7A130_provenance.
- NP247226.RAI9cciKArP5LPh39c3QKXzcubZS9cWw01X0ICLcJ5l7A130_assertion wasGeneratedBy ECO_0000203 NP247226.RAI9cciKArP5LPh39c3QKXzcubZS9cWw01X0ICLcJ5l7A130_provenance.